The European Society for Hemapheresis - short ESFH - was founded in 1984 with the aim of gathering European physicians, scientists, and allied health personnel working in the field of Hemapheresis with a vision to improve donor and patient care. The mission of ESFH is to advance knowledge in apheresis techniques through education, to consolidate and spread proven methods, and to open new paths in the collection of blood cells and treatment of diseases by apheresis.

Learn More

From the literature:

Webinars

ESFH 20th Congress  2018
13th/14th June 2018, Hospital La Fe, Valencia, Spain
www.esfh2018.com

 ESFH 2018 Valencia Web

Abstracts;  notification of acceptance to the Authors 25 April 2018 

The meeting will cover relevant aspects regarding clinical, technical and quality management, as well as novel research areas in apheresis and transfusion medicine. Topics discussed in this meeting will include extracorporeal photochemotherapy, plasmapheresis and self-sufficiency in Europe, ultrasounds and peripheral venous access, CAR-T cell therapies, poor mobilizers management, pathogen inactivation technologies, immunoadsorption and thrombotic microangiopathies.

Invitation (.pdf) for download  ,Registration
Program (.pdf)

 ESFH General Assembly
Thursday, June 14th, 12:00 -13:00.

Deadline for Early Registration
30 April 2018
at 23:59 (Spanish local time)

Webinars produced  by Terumo BCT with the collaboration of ESFH

Anticoagulation Management in Therapeutic Plasma Exchange
https://event.on24.com/wcc/r/1456764/D92CCED5B651D872414BAC48B2EC6CA0?partnerref=esfh 

Plasma Exchange: Multiple Venous Access Versus Peripheral Access?
http://event.on24.com/wcc/r/1394067/8ECB6E15DA4493C7768B1F97C4C80DCE?partnerref=esfh

What Technology Would You Use for Plasma Exchange?
http://event.on24.com/wcc/r/1343905/42FD04644AC1D9827165929D80BBA131?partnerref=esfh

Advancing Apheresis in Neurology: Review of Neurological Disease Indications for Plasma Exchange
https://event.on24.com/wcc/r/1456776/073F252EFC9FDEC2B81253C9FF382769?partnerref=esfh

Characterization of buffy coat-derived granulocytes for clinical use: a...

Recently an interesting investigation was published in Vox Sanguinis concerning in vitro evaluation of buffy coat derived granulocytes for the...

Mobilization of Hematopoietic Progenitor Cells from Allogeneic Healthy...

In this paper, the group from Pamplona shows data of stem cell mobilization with filgrastim (G-CSF) in 36 healthy family donors, of which 18...

Adverse events in apheresis: An update of the WAA registry data

In this paper the authors reviewed more than 50.000 extracorporeal procedures in 7.142 patients regarding incidence and severity of apheresis...